Low dose tranexamic acid reduces blood transfusion rate after total knee arthroplasty: A population-based study in Taiwan

Journal of the Formosan Medical Association

Volumn 116, Issue 1, 2017, Pages 24-31

  Liu, Kuan Lin ^a,b   Chen, Ing Ho ^a,b   Wen, Shu Hui ^b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

blood transfusion; drug effect; odds ratio; total knee arthroplasty; tranexamic acid

Indexed keywords

TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

AGED; ARTICLE; BLOOD TRANSFUSION; COMORBIDITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; FEMALE; HOSPITAL; HOSPITAL POLICY; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; TAIWAN; TOTAL KNEE ARTHROPLASTY; BLOOD LOSS, SURGICAL; CLINICAL TRIAL; FACTUAL DATABASE; INTRAVENOUS DRUG ADMINISTRATION; KNEE REPLACEMENT; MULTICENTER STUDY; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADMINISTRATION, INTRAVENOUS; AGED; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; DATABASES, FACTUAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES; TAIWAN; TRANEXAMIC ACID;

EID: 84956617329     PISSN: 09296646     EISSN: 18760821     Source Type: Journal    
DOI: 10.1016/j.jfma.2015.12.012     Document Type: Article

References (29)

1. 1 Duncan, C.M., Gillette, B.P., Jacob, A.K., Sierra, R.J., Sanchez-Sotelo, J., Smith, H.M., Venous thromboembolism and mortality associated with tranexamic acid use during total hip and knee arthroplasty. J Arthroplasty 30 (2015), 272–276.
2. 2 Park, J.H., Rasouli, M.R., Mortazavi, S.M., Tokarski, A.T., Maltenfort, M.G., Parvizi, J., Predictors of perioperative blood loss in total joint arthroplasty. J Bone Joint Surg Am 95 (2013), 1777–1783.
3. 3 Friedman, R., Homering, M., Holberg, G., Berkowitz, S.D., Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. J Bone Joint Surg Am 96 (2014), 272–278.
4. 4 Hill, G.E., Frawley, W.H., Griffith, K.E., Forestner, J.E., Minei, J.P., Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma 54 (2003), 908–914.
5. 5 Vamvakas, E.C., Blajchman, M.A., Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 113 (2009), 3406–3417.
6. 6 Allain, J.P., Stramer, S.L., Carneiro-Proietti, A.B., Martins, M.L., Lopes da Silva, S.N., Ribeiro, M., et al. Transfusion-transmitted infectious diseases. Biologicals 37 (2009), 71–77.
7. 7 Klika, A.K., Small, T.J., Saleh, A., Szubski, C.R., Chandran Pillai, A.L., Barsoum, W.K., Primary total knee arthroplasty allogenic transfusion trends, length of stay, and complications: nationwide inpatient sample 2000-2009. J Arthroplasty 29 (2014), 2070–2077.
8. 8 Culler, S.D., Jevsevar, D.S., Shea, K.G., Wright, K.K., Simon, A.W., The incremental hospital cost and length-of-stay associated with treating adverse events among Medicare beneficiaries undergoing TKA. J Arthroplasty 30 (2015), 19–25.
9. 9 Mannucci, P.M., Hemostatic drugs. N Engl J Med 339 (1998), 245–253.
10. 10 Zufferey, P., Merquiol, F., Laporte, S., Decousus, H., Mismetti, P., Auboyer, C., et al. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?. Anesthesiology 105 (2006), 1034–1046.
11. 11 Ker, K., Edwards, P., Perel, P., Shakur, H., Roberts, I., Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ, 344, 2012, e3054.
12. 12 Gillette, B.P., Maradit Kremers, H., Duncan, C.M., Smith, H.M., Trousdale, R.T., Pagnano, M.W., et al. Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. J Arthroplasty 28 (2013), 137–139.
13. 13 Moskal, J.T., Harris, R.N., Capps, S.G., Transfusion cost savings with tranexamic acid in primary total knee arthroplasty from 2009 to 2012. J Arthroplasty 30 (2015), 365–368.
14. 14 Poeran, J., Rasul, R., Suzuki, S., Danninger, T., Mazumdar, M., Opperer, M., et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ, 349, 2014, g4829.
15. 15 Ibrahim, S.A., Stone, R.A., Han, X., Cohen, P., Fine, M.J., Henderson, W.G., et al. Racial/ethnic differences in surgical outcomes in veterans following knee or hip arthroplasty. Arthritis Rheum 52 (2005), 3143–3151.
16. 16 Manley, M., Ong, K., Lau, E., Kurtz, S.M., Total knee arthroplasty survivorship in the United States Medicare population: effect of hospital and surgeon procedure volume. J Arthroplasty 24 (2009), 1061–1067.
17. 17 Baker, P., Dowen, D., McMurtry, I., The effect of surgeon volume on the need for transfusion following primary unilateral hip and knee arthroplasty. Surgeon 9 (2011), 13–17.
18. 18 Lau, R.L., Perruccio, A.V., Gandhi, R., Mahomed, N.N., The role of surgeon volume on patient outcome in total knee arthroplasty: a systematic review of the literature. BMC Musculoskelet Disord, 13, 2012, 250.
19. 19 Katz, J.N., Barrett, J., Mahomed, N.N., Baron, J.A., Wright, R.J., Losina, E., Association between hospital and surgeon procedure volume and the outcomes of total knee replacement. J Bone Joint Surg Am 86 (2004), 1909–1916.
20. 20 SooHoo, N.F., Lieberman, J.R., Ko, C.Y., Zingmond, D.S., Factors predicting complication rates following total knee replacement. J Bone Joint Surg Am 88 (2006), 480–485.
21. 21 Wen, C.P., Tsai, S.P., Chung, W.S., A 10-year experience with universal health insurance in Taiwan: measuring changes in health and health disparity. Ann Intern Med 148 (2008), 258–267.
22. 22 Cheng, C.L., Kao, Y.H., Lin, S.J., Lee, C.H., Lai, M.L., Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 20 (2011), 236–242.
23. 23 Snijders, T., Bosker, R., Multilevel analysis: an introduction to basic and advanced multilevel modeling. 2nd ed., 2012, Sage Publications, New York.
24. 24 Soni, A., Saini, R., Gulati, A., Paul, R., Bhatty, S., Rajoli, S.R., Comparison between intravenous and intra-articular regimens of tranexamic acid in reducing blood loss during total knee arthroplasty. J Arthroplasty 29 (2014), 1525–1527.
25. 25 Sarzaeem, M.M., Razi, M., Kazemian, G., Moghaddam, M.E., Rasi, A.M., Karimi, M., Comparing efficacy of three methods of tranexamic acid administration in reducing hemoglobin drop following total knee arthroplasty. J Arthroplasty 29 (2014), 1521–1524.
26. 26 Patel, J.N., Spanyer, J.M., Smith, L.S., Huang, J., Yakkanti, M.R., Malkani, A.L., Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study. J Arthroplasty 29 (2014), 1528–1531.
27. 27 Alshryda, S., Sukeik, M., Sarda, P., Blenkinsopp, J., Haddad, F.S., Mason, J.M., A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement. Bone Joint J 96 (2014), 1005–1015.
28. 28 Iwai, T., Tsuji, S., Tomita, T., Sugamoto, K., Hideki, Y., Hamada, M., Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty. Int Orthop 37 (2013), 441–445.
29. 29 Wang, H., Shen, B., Zeng, Y., Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials. Knee 21 (2014), 987–993.